TID 10022 Radiopharmaceutical Administration Event Data

TID 10022 Radiopharmaceutical Administration Event Data
Prev	Radiopharmaceutical Radiation Dose SR IOD Templates	Next

The Radiopharmaceutical Administration Event conveys the dose and assay and time information of a single radiopharmaceutical event. A Radiopharmaceutical Administration event is one radioactive pharmaceutical administered to a patient.

Type:: Extensible
Order:: Significant

Table TID 10022. Radiopharmaceutical Administration Event Data

	NL	Rel with Parent	VT	Concept Name	VM	Req Type	Condition	Value Set Constraint
1			CONTAINER	EV (113502, DCM, "Radiopharmaceutical Administration")	1	M
2	>	CONTAINS	CODE	EV (F-61FDB, SRT, "Radiopharmaceutical agent")	1	M		DCID 25 “Radiopharmaceuticals” DCID 4021 “PET Radiopharmaceutical”
3	>>	HAS PROPERTIES	CODE	EV (C-10072, SRT, "Radionuclide")	1	M		DCID 18 “Isotopes in Radiopharmaceuticals” DCID 4020 “PET Radionuclide”
4	>>	HAS PROPERTIES	NUM	EV (R-42806, SRT, "Radionuclide Half Life")	1	M		UNITS = EV (s, UCUM, "seconds")
5	>	CONTAINS	NUM	EV (123007, DCM, "Radiopharmaceutical Specific Activity")	1	U		UNITS = EV (Bq/mmol, UCUM, "Bq/mmol")
6	>	CONTAINS	UIDREF	EV (113503, DCM, "Radiopharmaceutical Administration Event UID")	1	M
7	>	CONTAINS	CODE	EV (113505, DCM, "Intravenous Extravasation Symptoms")	1-n	U		DCID 10043 “Intravenous Extravasation Symptoms”
8	>	CONTAINS	NUM	EV (113506, DCM, "Estimated Extravasation Activity")	1	U		UNITS = EV(%, UCUM, "percent")
9	>	CONTAINS	DATETIME	EV (123003, DCM, "Radiopharmaceutical Start DateTime")	1	M
10	>	CONTAINS	DATETIME	EV (123004, DCM, "Radiopharmaceutical Stop DateTime")	1	U
11	>	CONTAINS	NUM	EV (113507, DCM, "Administered activity")	1	M		UNITS = EV (MBq, UCUM, "MBq")
12	>	CONTAINS	NUM	EV (123005, DCM, "Radiopharmaceutical Volume")	1	U		UNITS = EV (cm3, UCUM, "cm3")
13	>	CONTAINS	NUM	EV (113508, DCM, "Pre-Administration Measured Activity")	1	U		UNITS = EV (MBq, UCUM, "MBq")
14	>>	HAS OBS CONTEXT	CODE	EV (113540, DCM, "Activity Measurement Device")	1	U		DCID 10041 “Source of Radioisotope Activity Information”
15	>>	HAS OBS CONTEXT	INCLUDE	DTID 1002 “Observer Context”	1-n	U
16	>	CONTAINS	NUM	EV (113509, DCM, "Post-Administration Measured Activity")	1	U		UNITS = EV (MBq, UCUM, "MBq")
17	>>	HAS OBS CONTEXT	CODE	EV (113540, DCM, "Activity Measurement Device")	1	U		DCID 10041 “Source of Radioisotope Activity Information”
18	>>	HAS OBS CONTEXT	INCLUDE	DTID 1002 “Observer Context”	1-n	U
19	>	CONTAINS	INCLUDE	DTID 10023 “Organ Dose”	1-n	U
20	>	CONTAINS	CODE	EV (G-C340, SRT, "Route of administration")	1	M		BCID 11 “Route of Administration”
21	>>	HAS PROPERTIES	CODE	EV (G-C581, SRT, "Site of")	1	MC	IF Row 22 equals (G-D101, SRT, "Intravenous route") or (G-D103, SRT, "Intramuscular route")	DCID 3746 “Percutaneous Entry Site”
22	>>>	HAS CONCEPT MOD	CODE	EV (G-C171, SRT, "Laterality")	1	MC	IF Row 23 has laterality	DCID 244 “Laterality”
23	>	HAS OBS CONTEXT	INCLUDE	DTID 1020 “Person Participant”	1-n	M		$PersonProcedureRole = EV (113851, DCM, "Irradiation Administering")
24	>	CONTAINS	CODE	EV (121147, DCM, "Billing Code(s) ")	1-n	U
25	>	CONTAINS	CODE	EV (113510, DCM, "Drug Product Identifier")	1-n	U
26	>	CONTAINS	TEXT	EV (111529, DCM, "Brand Name")	1	U
27	>	CONTAINS	TEXT	EV (113511, DCM, "Radiopharmaceutical Dispense Unit Identifier")	1	U
28	>>	CONTAINS	TEXT	EV (113512, DCM, "Radiopharmaceutical Lot Identifier")	1-n	U
29	>>	CONTAINS	TEXT	EV (113513, DCM, "Reagent Vial Identifier")	1-n	U
30	>>	CONTAINS	TEXT	EV (113514, DCM, "Radionuclide Identifier")	1-n	U
31	>	CONTAINS	TEXT	EV (113516, DCM, "Prescription Identifier")	1	U
32	>	CONTAINS	TEXT	EV (121106, DCM, "Comment")	1	U

Content Item Descriptions

Row 4	The value of Half-life that was used for computing the decay of the administered radiopharmaceutical. It is not intended for use by the receiver for any further computation.
Row 5	Activity per unit mass of the radiopharmaceutical at Radiopharmaceutical Start Time
Row 6	Unique identification of a single radiopharmaceutical administration event.
Row 8	The estimated percentage of administered activity lost at the injection site. The estimation includes extravasation, paravenous administration and leakage at the injection site.
Row 9	The time the radiopharmaceutical was administered to the patient for imaging purposes.
Row 11	Total amount of radioactivity administered to the patient at Radiopharmaceutical Start Time. It is a computed field from the TID 10022 Pre-Administration Measured Activity Row 13, TID 10022 Post-Administration Measured Activity Row 17, Radionuclide Half Life Row 4 and Radiopharmaceutical Start Time Row 9. Does not include estimated extravasation activity.
Rows 13, 16	Observation DateTime (0040,A032) shall be used to record when the measurement was taken.
Row 23	Identifies the person administering the product.
Row 24	The billing codes for the preparation and administration of the radiopharmaceutical. It does not include performance and interpretation of the imaging.
Row 25	Registered drug establishment code for the product. A coding scheme example is NDC, WHO-DDE or RxNorm. Multiple entries can be used for equivalent drug product codes.
Row 27	The human readable identification of the specific radiopharmaceutical quantity (dose) administered to the patient.
Row 28	Identifies the vial, batch or lot number from which the individual radiopharmaceutical quantity (dose) was produced. Row 27 the Radiopharmaceutical Identifier records the identification for each individual dose.
Row 29	Identifies the lot or unit serial number for the reagent component for the radiopharmaceutical identified in row 27.
Row 30	Identifies the lot or unit serial number for the radionuclide component for the radiopharmaceutical identified in row 27.